# Rare Neurological Disease Neuroimaging Services | IXICO

IXICO delivers neuroimaging and biomarker solutions for rare neurological diseases including Spinocerebellar Ataxia (SCA) and Friedreich's Ataxia (FA). Explore our CNS capabilities.

# Rare Neurological Disease Neuroimaging Services

![Regions Blank](/assets/element-images/Regions-Blank__FitMaxWzk2MCw1NDBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp "Regions Blank")

IXICO works across many rare neurological diseases and can develop, optimise and apply advanced imaging and analytical techniques to produce disease-focused imaging endpoints.

Example indications include: Spinocerebellar Ataxia (SCA), Friedreich's Ataxia (FA), Amyotrophic Lateral Sclerosis (ALS), and Cerebral Amyloid Angiopathy (CAA).  In addition, the IXI™ platform's analysis pipelines can also be optimised for paediatric populations.

## Recent Scientific Publications

**Neuroimaging Biomarkers for Friedreich's Ataxia: A Cross-Sectional Analysis of the TRACK-FA Study**

- **Date:** March 22nd 2025
- **Synopsis:** This study aimed to quantify differences in the brain and spinal cord between individuals with Friedreich's ataxia and healthy controls.
- **Therapeutic Indication:** Friedreich Ataxia

[**>View Study**](/news-and-resources/publications/neuroimaging-biomarkers-for-friedreich-ataxia-a-cross-sectional-analysis-of-the-track-fa-study/)

**MR Imaging in Ataxias: Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers**

- **Date:** May 18th 2023
- **Synopsis:** Recommendations for both a basic structural MRI protocol and an advanced multi-modal MRI protocol including acceptable ranges of acquisition parameters for adequate data quality.
- **Therapeutic Indication:** Friedreich Ataxia

**[>View Study](/assets/downloads/MR-Imaging-in-Ataxias-Consensus-Recommendations-by-the-Ataxia-Global-Initiative-Working-Group-on-MRI-Biomarkers-June-2023.pdf)**